Comparing anti-hyperglycemic activity and acute oral toxicity of three different trivalent chromium complexes in mice

Food and Chemical Toxicology

Volumn 50, Issue 5, 2012, Pages 1623-1631

  Li, Fang ^a   Wu, Xiangyang ^a   Zou, Yanmin ^a   Zhao, Ting ^a   Zhang, Min ^a   Feng, Weiwei ^a   Yang, Liuqing ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Acute oral toxicity; Anti hyperglycemic activity; Chromium complexes; Coordinated ligands; Diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHROMIUM DERIVATIVE; CHROMIUM FOLATE COMPLEX; CHROMIUM RUTIN COMPLEX; CHROMIUM STACHYOSE COMPLEX; GLUCOSE; GLYCOGEN; METFORMIN; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG SYNTHESIS; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; LD 50; MALE; MOUSE; NONHUMAN; WEIGHT GAIN;

ADMINISTRATION, ORAL; ALLOXAN; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHROMIUM; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOGLYCEMIC AGENTS; LETHAL DOSE 50; MALE; MICE; MICE, INBRED ICR; TOXICITY TESTS, ACUTE;

MUS;

EID: 84862779429     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.02.012     Document Type: Article

References (50)

1. Anderson R.A. Lack of toxicity of chromium chloride and chromium picolinate in rats. J. Am. Coll. Nutr. 1997, 16:273-279.
2. Anderson R.A. Chromium and insulin resistance. Nutr. Res. Rev. 2003, 16:267-275.
3. Bailey M.M., Boohaker J.G., Sawyer R.D., Behling J.E., Rasco J.F., Jernigan J.J., Hood R.D., Vincent J.B. Exposure of pregnant mice to chromium picolinate results in skeletal defects in their offspring. Birth Defects Res. Part B 2006, 77:244-249.
4. Bailey M.M., Townsend M.B., Jernigan P.L., Sturdivant J., Rasco J.F., Vincent J.B., Hood R.D. Prenatal and lactational exposure to chromium picolinate and picolinic acid - the effects on the neurological development of mice. Neurotoxicol. Teratol. 2007, 29. 408-408.
5. Buccolo G., David M. Quantitative determination of serum triglycerides by use of enzyme. Clin. Chem. 1973, 19:476-482.
6. Carroll N.V., Longly R.W., Joseph H.R. Determination of glycogen in liver and muscle by use of anthrone reagent. J. Biol. Chem. 1956, 220:583-593.
7. Chaudhary S., Pinkston J., Rabile M.M., Van Horn J.D. Unusual reactivity in a commercial chromium supplement compared to baseline DNA cleavage with synthetic chromium complexes. J. Inorg. Biochem. 2005, 99:787-794.
8. Chen X.-M., Fu D.-X., Ou Y.-F. Preparation of Cr(III)-amorphophallus konjac oligosaccharide complex and study on its effect on blood glucose in mice. Chin. J. Biochem. 2003, 24.
9. Deng, Y., 2007. Study of chromium complexes with bacalin bacalein and mdg-1 polysaccharides for anti-hyperglycemia. A Dissertation of Shanghai Jiao Tong University for the Degree of Master.
10. Dogukan A., Tuzcu M., Juturu V., Cikim G., Ozercan I., Komorowski J., Sahin K. Effects of chromium histidinate on renal function, oxidative stress, and heat-shock proteins in fat-fed and streptozotocin-treated rats. J. Renal Nutr. 2010, 20:112-120.
11. Ferrannini E., Lanfranchi A., Rohner-Jeanrenaud F., Manfredini G., Van de Werve G. Influence of long-term diabetes on liver glycogen metabolism in the rat. Metabolism 1990, 39:1082-1088.
12. Ghosh R., Sharatchandra K., Rita S., Thokchom I. Hypoglycemic activity of Ficus hispida (bark) in normal and diabetic albino rats. Indian J. Phamacol. 2004, 36:222-225.
13. Halliwell, B., Gutteridge, J., 1985. Free Radicals in Biology and Medicine. Oxford, London.
14. Hamden K., Boujbiha M.A., Masmoudi H., Ayadi F.M., Jamoussi K., Elfeki A. Combined vitamins (C and E) and insulin improve oxidative stress and pancreatic and hepatic injury in alloxan diabetic rats. Biomed. Pharmacother. 2009, 63:95-99.
15. Hems D.A., Harmon C.S., Whitton P.D. Inhibition by parathyroid hormone of glycogen synthesis in the perfused rat liver. FEBS Lett. 1975, 58:167-169.
16. Jain S.K., Kannan K. Chromium chloride inhibits oxidative stress and TNF-α secretion caused by exposure to high glucose in cultured U937 monocytes. Biochem. Biophys. Res. Commun. 2001, 289:687-691.
17. Jain S.K., Rains J.L., Croad J.L. Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-α, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radical Biol. Med. 2007, 43:1124-1131.
18. Jain S.K., Rains J.L., Croad J.L. High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes. Antioxid. Redox Signal. 2007, 9:1581-1590.
19. Jennings D.S., Brevard P.B., Flohr J.A., Gloeckner J.W. Chromium nicotinate supplementation: effects on body composition and strength in female colleigate athletes participating in off-season training. J. Am. Diet. Assoc. 1997, 97:A65.
20. Kim D.-S., Kim T.-W., Park I.-K., Kang J.-S., Om A.-S. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone-treated rats. Metabolism 2002, 51:589-594.
21. Krejpcio Z., Wojciak R.W., Krol E. The effect of hyperglycemia on zinc, copper and chromium status in STZ-induced diabetic rats. Trace Elem. Electrolytes 2011, 28:156-161.
22. Król E., Krejpcio Z. Chromium(III) propionate complex supplementation improves carbohydrate metabolism in insulin-resistance rat model. Food Chem. Toxicol. 2010, 48:2791-2796.
23. Król E., Krejpcio Z. Evaluation of anti-diabetic potential of chromium(III) propionate complex in STZ injected rats fed high diets. Food Chem. Toxicol 2011, 10.1016/j.fct.2011.09.006.
24. Li F., Wu X., Yang L., Zou Y., Zhao J., Zhang R. Synthesis and characterization of the chromium(III)complexes with rutin and quercetin. Chem. Res. Appl. 2009, 21:899-902.
25. Liu B., Qin Z.-K., Lin X.-M., Mei L., Liu W.-S., Han B.-Q. Promotion effect of chitooligosaccharides and its derivatives on pancreatic islet cells proliferation and insulin secretion. J. Clin. Rehab. Tissue Eng. Res. 2009, 13:513-516.
26. Loomis, T.A., Hayes, A.W., 1996. Loomis's Essentials of Toxicology. Academic Press, San Diego, California.
27. Lukaski H.C., Siders W.A., Penland J.G. Chromium picolinate supplementation in women: effects on body weight, composition, and iron status. Nutrition 2007, 23:187-195.
28. Machaliński B., Walczak M., Syrenicz A., Machalińska A., Grymuła K., Stecewicz I., Wiszniewska B., Dabkowska E. Hypoglycemic potency of novel trivalent chromium in hyperglycemic insulin-deficient rats. J. Trace Elem. Med. Biol. 2006, 20:33-39.
29. Martin J., Wang Z.Q., Zhang X.H., Wachtel D., Volaufova J., Matthews D.E., Cefalu W.T. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 2006, 29:1826-1832.
30. Moreira E.D., Neves R.C.S., Nunes Z.O., de Almeida M.C.C., Mendes A.B.V., Fittipaldi J.A.S., Ablan F. Glycemic control and its correlates in patients with diabetes in Venezuela: results from a nationwide survey. Diabetes Res. Clin. Pract. 2010, 87:407-414.
31. Nair S.A., Shylesh B.S., Gopakumar B., Subramoniam A. Anti-diabetes and hypoglycaemic properties of Hemionitis arifolia (Burm.) Moore in rats. J. Ethnopharmacol. 2006, 106:192-197.
32. Preuss H.G., Echard B., Perricone N.V., Bagchi D., Yasmin T., Stohs S.J. Comparing metabolic effects of six different commercial trivalent chromium compounds. J. Inorg. Biochem. 2008, 102:1986-1990.
33. Sharma S., Agrawal R.P., Choudhary M., Jain S., Goyal S., Agarwal V. Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes. J. Trace Elem. Med. Biol. 2011, 10.1016/j.jtemb.2011.03.003.
34. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010, 87:4-14.
35. Shiau S.-Y., Lin S.-F. Effect of supplemental dietary chromium and vanadium on the utilization of different carbohydrates in tilapia, Oreochromis niloticus×O. aureus. Aquaculture 1993, 110:321-330.
36. Shrivastava H.Y., Ravikumar T., Shanmugasundaram N., Babu M., Unni Nair B. Cytotoxicity studies of chromium(III) complexes on human dermal fibroblasts. Free Radical Biol. Med. 2005, 38:58-69.
37. Sreekanth R., Pattabhi V., Rajan S.S. Molecular basis of chromium insulin interactions. Biochem. Biophys. Res. Commun. 2008, 369:725-729.
38. Staniek H., Krejpcio Z. The effects of tricentric chromium(III) propionate complex supplementation on pregnancy outcome and maternal and foetal mineral status in rat. Food Chem. Toxicol. 2009, 47:2673-2678.
39. Staniek H., Kostrzewska-Poczekaj M., Arndt M., Szyfter K., Krejpcio Z. Genotoxicity assessment of chromium(III) propionate complex in the rat model using the comet assay. Food Chem. Toxicol. 2010, 48:89-92.
40. Staniek H., Krejpcio Z., Iwanik K. Evaluation of the acute oral toxicity class of tricentric chromium(III) propionate complex in rat. Food Chem. Toxicol. 2010, 48:859-864.
41. Trent L.K., Tiedingcancel D. Effects of chromium picolinate on body composition. J. Sport Med. Phys. Fit. 1995, 35:273-280.
42. Vincent J.B., Sun Y.J., Clodfelder B.J. Biomimetic chromium complex enhances insulin sensitivity in healthy and type II diabetic model rats. Diabetes 2001, 50:A508.
43. Vrtovec M., Vrtovec B., Briski A., Kocijancic A., Anderson R.A., Radovancevic B. Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus. Am. Heart J. 2005, 149:632-636.
44. Wu X.-Y., Li F., Xu W.-D., Zhao J.-L., Zhao T., Liang L.-H., Yang L.-Q. Anti-hyperglycemic activity of chromium(III) malate complex in alloxan-induced diabetic rats. Biol. Trace Elem. Res. 2011, 143:1031-1043.
45. Yanardag R., Demirci T.B., ülküseven B., Bolkent S., Tunali S., Bolkent S. Synthesis, characterization and antidiabetic properties of N1-2,4-dihydroxybenzylidene-N4-2-hydroxybenzylidene-S-methyl-thiosemicarbazidato-oxovanadium(IV). Eur. J. Med. Chem. 2009, 44:818-826.
46. 3 improves insulin responsiveness and reduces whole body glucose tolerance. FEBS Lett. 2005, 579:1458-1464.
47. 3. J. Inorg. Biochem. 2006, 100:1187-1193.
48. Yang, L., Li, F., Wu, X., Zhang, M., Zhang, R., Yan, S., 2010. A folic acid chromium(III) complex and its preparation method. China Patent, CN101691369A.
49. Yu W., Sipowicz M.A., Haines D.C., Birely L., Diwan B.A., Riggs C.W., Kasprzak K.S., Anderson L.M. Preconception urethane or chromium(III) treatment of male mice: multiple neoplastic and non-neoplastic changes in offspring. Toxicol. Appl. Pharmacol. 1999, 158:161-176.
50. 3+) complex. Sichuan J. Phys. Sci. 2002, 24:69-71.